Primary Sjögren's syndrome and high type I interferon signalling in a kindred with C2 deficiency.

Willemsen, Mathijs; Van Nieuwenhove, Erika; Seyed Tabib, Nasim Sadat; Staels, Frederik; Schrijvers, Rik; De Somer, Lien; Liston, Adrian; Humblet-Baron, Stephanie; Wouters, Carine

Willemsen, Mathijs; Van Nieuwenhove, Erika; Seyed Tabib, Nasim Sadat; Staels, Frederik; Schrijvers, Rik; De Somer, Lien; Liston, Adrian; Humblet-Baron, Stephanie; Wouters, Carine.

Afiliación

Willemsen M; Laboratory of Adaptive Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven.
Van Nieuwenhove E; VIB-KU Leuven Center for Brain and Disease Research.
Seyed Tabib NS; Laboratory of Adaptive Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven.
Staels F; VIB-KU Leuven Center for Brain and Disease Research.
Schrijvers R; Division Pediatric Rheumatology, Department of Pediatrics, University Hospitals Leuven.
De Somer L; Department of Chronic Diseases, Metabolism and Ageing, TARGID, KU Leuven.
Liston A; Laboratory of Adaptive Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven.
Humblet-Baron S; VIB-KU Leuven Center for Brain and Disease Research.
Wouters C; Allergy and Clinical Immunology Research Group, Department of Microbiology, Immunology and Transplantation.

Rheumatol Adv Pract ; 6(1): rkac018, 2022.

Article en En | MEDLINE | ID: mdl-35368972

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Rheumatol Adv Pract Año: 2022 Tipo del documento: Article